Health Care & Life Sciences » Medical Equipment & Supplies | Green Cross Medical Science Corp.

Green Cross Medical Science Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
61,986
81,335
89,298
86,163
98,389
Cost of Goods Sold (COGS) incl. D&A
50,852
67,027
76,786
74,673
84,007
Gross Income
11,134
14,308
12,512
11,490
14,382
SG&A Expense
8,318
9,839
11,074
13,386
14,249
EBIT
2,799
4,449
1,388
1,949
72
Unusual Expense
340
86
344
185
1,583
Non Operating Income/Expense
97
209
292
404
116
Interest Expense
447
460
534
553
512
Pretax Income
1,914
4,117
219
3,088
2,128
Income Tax
264
400
345
528
216
Equity in Affiliates
-
-
39
-
-
Consolidated Net Income
2,178
3,717
603
2,560
2,344
Net Income
2,178
3,717
729
1,891
2,065
Net Income After Extraordinaries
2,178
3,717
729
1,891
2,065
Net Income Available to Common
2,178
3,717
729
1,891
2,065
EPS (Basic)
290.00
488.00
76.00
198.00
217.00
Basic Shares Outstanding
8
8
10
10
10
EPS (Diluted)
290.42
487.88
76.29
197.81
216.93
Diluted Shares Outstanding
8
8
10
10
10
EBITDA
3,612
5,806
3,490
700
2,814
Other Operating Expense
18
19
50
52
61
Non-Operating Interest Income
-
5
1
3
11
Minority Interest Expense
-
-
126
669
279

About Green Cross Medical Science

View Profile
Address
107 Ihyeon-ro 30beon-gil
Yongin-si GY 16924
Korea, Republic Of
Employees -
Website http://www.greencrossms.com
Updated 09/14/2018
Green Cross Medical Science Corp. engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies. It operates through following business divisions: Diagnostic Medicine, Blood Bag, Dialysate, and Diabetes. The company offers diagnostic reagents including diagnostic kit (ELISA), pregnancy and ovulation tests, rapid tests, magnetic immuno-chromatographic test (MICT), bleeding disorder tests, molecular subtyping tests, biochemical reagents, real-time polymerase chain reaction (PCR), and allergy tests.